Redirect Notice

Looks like you clickedhttps://www.globenewswire.com/news-release/2020/11/19/2129949/0/en/Bio-Path-Holdings-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-BP1002.html

If you do not want to visit that page, you can close this browser tab.